PGH doctor dies after contracting COVID-19 a second time | Inquirer

PGH doctor dies after contracting COVID-19 a second time

By: - Reporter /
/ 04:01 AM August 24, 2020

MANILA, Philippines — A doctor of the Philippine General Hospital (PGH) in Manila died on Sunday morning after more than a month of fighting the new coronavirus disease (COVID-19).

Dr. Kathlynne Anne “Kharen” Abat-Senen, a 43-year-old neonatologist and infectious disease expert, was first admitted to the hospital in June after she tested positive for the virus, her husband Jerome said in an earlier interview with GMA .

But two days after her discharge, she started feeling worse, leading to her return on July 10 to the PGH intensive care unit where she was again found positive for COVID-19.

Article continues after this advertisement

Senen was also the only neonatologist in Valenzuela City, where she had to make rounds in various hospitals that could have exposed her to the virus the first time, Jerome said.

The PGH doctor was among at least 38 medical front-liners who died due to the disease.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

business
entertainment
entertainment
globalnation
sports
TAGS: coronavirus Philippines, COVID-19, PGH doctor

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.